[HTML][HTML] The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes
JD Erusalimsky - Redox Biology, 2021 - Elsevier
The soluble receptor for advanced glycation end-products (sRAGE) has been classically
considered a sink for pro-inflammatory RAGE ligands and as such has been associated with …
considered a sink for pro-inflammatory RAGE ligands and as such has been associated with …
A role for advanced glycation end products in molecular ageing
K Zgutka, M Tkacz, P Tomasiak… - International journal of …, 2023 - mdpi.com
Ageing is a composite process that involves numerous changes at the cellular, tissue, organ
and whole-body levels. These changes result in decreased functioning of the organism and …
and whole-body levels. These changes result in decreased functioning of the organism and …
Dietary advanced glycation end products and aging
C Luevano-Contreras, K Chapman-Novakofski - Nutrients, 2010 - mdpi.com
Advanced glycation end products (AGEs) are a heterogeneous, complex group of
compounds that are formed when reducing sugar reacts in a non-enzymatic way with amino …
compounds that are formed when reducing sugar reacts in a non-enzymatic way with amino …
The aging kidney revisited: a systematic review
D Bolignano, F Mattace-Raso, EJG Sijbrands… - Ageing research …, 2014 - Elsevier
As for the whole human body, the kidney undergoes age-related changes which translate in
an inexorable and progressive decline in renal function. Renal aging is a multifactorial …
an inexorable and progressive decline in renal function. Renal aging is a multifactorial …
Dangers within: DAMP responses to damage and cell death in kidney disease
DL Rosin, MD Okusa - Journal of the American Society of …, 2011 - journals.lww.com
The response to exogenous pathogens leads to activation of innate immunity through the
release of pathogen-associated molecular patterns (PAMPs) and their binding to pattern …
release of pathogen-associated molecular patterns (PAMPs) and their binding to pattern …
The role of advanced glycation end products and its soluble receptor in kidney diseases
M Steenbeke, R Speeckaert, S Desmedt… - International Journal of …, 2022 - mdpi.com
Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic
inflammation, which may lead to an increase in the synthesis of advanced glycation end …
inflammation, which may lead to an increase in the synthesis of advanced glycation end …
Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year …
JW Nin, A Jorsal, I Ferreira, CG Schalkwijk… - Diabetes …, 2011 - Am Diabetes Assoc
OBJECTIVE To investigate the associations of plasma levels of advanced glycation end
products (AGEs) with incident cardiovascular disease (CVD) and all-cause mortality in type …
products (AGEs) with incident cardiovascular disease (CVD) and all-cause mortality in type …
Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a …
J Sabbatinelli, S Castiglione, F Macrì, A Giuliani… - Cardiovascular …, 2022 - Springer
Background Advanced glycation end-products (AGEs) and their interaction with the receptor
for advanced glycation end-products (RAGE) play a pivotal role in the development and …
for advanced glycation end-products (RAGE) play a pivotal role in the development and …
Advanced glycation end‐products and the kidney
M Busch, S Franke, C Rüster… - European journal of …, 2010 - Wiley Online Library
Eur J Clin Invest 2010; 40 (8): 742–755 Abstract Background Advanced glycation end‐
products (AGEs) are increased in situations with hyperglycemia and oxidative stress such as …
products (AGEs) are increased in situations with hyperglycemia and oxidative stress such as …
Uremic toxins, oxidative stress, atherosclerosis in chronic kidney disease, and kidney transplantation
E Wojtaszek, U Oldakowska-Jedynak… - oxidative medicine …, 2021 - Wiley Online Library
Patients with chronic kidney disease (CKD) are at a high risk for cardiovascular disease
(CVD), and approximately half of all deaths among patients with CKD are a direct result of …
(CVD), and approximately half of all deaths among patients with CKD are a direct result of …